Hepatic fascioliasis: case report and review
Open Access
- 1 February 1996
- journal article
- case report
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 38 (1) , 69-73
- https://doi.org/10.1590/s0036-46651996000100013
Abstract
A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up Based on this experience and few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis.Keywords
This publication has 13 references indexed in Scilit:
- TREMATODE INFECTIONSInfectious Disease Clinics of North America, 1993
- Type I hypersensitivity reactions in intestinal mucosae from rats infected with Fasciola hepaticaParasite Immunology, 1993
- Detection of antibodies and circulating excretory-secretory antigens for assessing cure in patients with fascioliasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Human fascioliasis successfully treated with triclabendazoleAustralian and New Zealand Journal of Medicine, 1992
- Subcutaneous fascioliasis: a case reportThe Korean Journal of Parasitology, 1991
- SINGLE TREATMENT OF INVASIVE FASCIOLIASIS WITH TRICLABENDAZOLEThe Lancet, 1989
- Increased systemic availability of albendazole when taken with a fatty mealEuropean Journal of Clinical Pharmacology, 1988
- Fasciola hepatica: Action in vitro of triclabendazole on immature and adult stagesExperimental Parasitology, 1987
- Unsuccessful Use of Praziquantel to Treat Acute Fascioliasis in ChildrenThe Journal of Infectious Diseases, 1986
- Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazoleVeterinary Record, 1983